<DOC>
	<DOC>NCT01512134</DOC>
	<brief_summary>The purpose of this clinical study is to investigate the safety and efficacy of deep brain stimulation (DBS) as a treatment option for obesity.</brief_summary>
	<brief_title>Deep Brain Stimulation for the Treatment of Obesity</brief_title>
	<detailed_description>The purpose of this clinical study is to investigate the safety and efficacy of deep brain stimulation (DBS) as a treatment option in the management of severe, treatment refractory, morbid obesity.</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<criteria>At least 24 months post RouxenY gastric bypass surgery without evidence of a sustained improvement in BMI after gastric bypass surgery for at least 6 months. Participant is willing to comply with all followup evaluations at the specified times Participant is able to provide informed consent Fluent in English Medical contraindications for general anesthesia, craniotomy, or DBS surgery Evidence of neurological disorders, e.g., multiple sclerosis, Parkinson's disease and ischemic stroke, or severe brain atrophy or the presence of subdural hygromas or subdural hematomas. Severe cardiovascular, pulmonary, renal, liver, hematological disease, severe coagulopathy, acute infectious process</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Obesity</keyword>
	<keyword>DBS</keyword>
</DOC>